Navega Therapeutics, Inc.
Biotechnology company · San Diego, California, United States
Navega Therapeutics, Inc. is a biotechnology company headquartered in San Diego, California, United States. It has received 8 US government small-business research awards (SBIR/STTR) from health agencies, $8.3 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $1.3 million sold in a notice filed in 2026.
Navega Therapeutics at a glance
What does Navega Therapeutics do?
US government research funding
8 SBIR/STTR small-business research awards from US health agencies, $8.3 million in total (2019 to 2025). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1.3 million sold (2026).
Frequently asked questions about Navega Therapeutics
Where is Navega Therapeutics headquartered?
Navega Therapeutics, Inc. is headquartered in San Diego, California, United States.
What does Navega Therapeutics do?
Navega Therapeutics, Inc. is a biotechnology company.
Similar companies
- BioAtla, Inc.San Diego, California, United States
- Neurocrine Biosciences IncSan Diego, California, United States
- ImmunityBio, Inc.San Diego, California, United States
- Sorrento Therapeutics, Inc.San Diego, California, United States
- Protego Biopharma, Inc.San Diego, California, United States
- Tempo Therapeutics, Inc.San Diego, California, United States
- Fate Therapeutics IncSan Diego, California, United States
- ImageneBio, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences